Interferon beta-responsive inclusion body myositis in a hepatitis C virus carrier

Neurology. 2004 Aug 10;63(3):587-8. doi: 10.1212/01.wnl.0000133411.10574.ba.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antiviral Agents / therapeutic use*
  • Carrier State / blood
  • Carrier State / virology
  • Disease Progression
  • Hepacivirus / isolation & purification
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / pathology
  • Humans
  • Interferon-beta / therapeutic use*
  • Kidney Failure, Chronic / complications
  • Male
  • Muscle Weakness / etiology
  • Muscle, Skeletal / pathology
  • Muscle, Skeletal / virology
  • Myositis, Inclusion Body / drug therapy*
  • Myositis, Inclusion Body / etiology
  • Myositis, Inclusion Body / pathology
  • Myositis, Inclusion Body / virology
  • RNA, Viral / analysis
  • RNA, Viral / blood
  • Viral Load
  • Viremia / complications

Substances

  • Antiviral Agents
  • RNA, Viral
  • Interferon-beta